Some properties of uridine-cytidine kinase from a human malignant lymphoma.
D000255:Adenosine Triphosphate / Q000008:administration & dosage; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007527:Isoenzymes / Q000378:metabolism; D007700:Kinetics; D008223:Lymphoma / Q000201:enzymology*; D008274:Magnesium / Q000494:pharmacology; D010770:Phosphotransferases / Q000378:metabolism*; D013696:Temperature; D014529:Uridine / Q000031:analogs & derivatives / Q000494:pharmacology; D014541:Uridine Kinase / Q000037:antagonists & inhibitors / Q000378:metabolism*
D007527:Isoenzymes; D000255:Adenosine Triphosphate; D010770:Phosphotransferases; D014541:Uridine Kinase; D008274:Magnesium; D014529:Uridine